Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510.

Wind SS, Jansen MAA, Rijsbergen M, van Esdonk MJ, Ziagkos D, Cheng WC, Niemeyer-van der Kolk T, Korsten J, Gruszka A, Schmitz-Rohmer D, Bonnel D, Legouffe R, Barré F, Bekkenk MW, de Haas ERM, Quint KD, Schnidar H, Rolli M, Streefkerk HJ, Burggraaf J, Vermeer MH, Rissmann R

Open source

DOI: 10.3390/cancers15051485
Published: 2023 Feb 27
Container: Cancers
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers15051485,
  title = {Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510.},
  author = {Wind SS and Jansen MAA and Rijsbergen M and van Esdonk MJ and Ziagkos D and Cheng WC and Niemeyer-van der Kolk T and Korsten J and Gruszka A and Schmitz-Rohmer D and Bonnel D and Legouffe R and Barré F and Bekkenk MW and de Haas ERM and Quint KD and Schnidar H and Rolli M and Streefkerk HJ and Burggraaf J and Vermeer MH and Rissmann R},
  year = {2023},
  journal = {Cancers},
  doi = {10.3390/cancers15051485},
  url = {https://doi.org/10.3390/cancers15051485}
}

RIS

TY  - JOUR
TI  - Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510.
AU  - Wind SS
AU  - Jansen MAA
AU  - Rijsbergen M
AU  - van Esdonk MJ
AU  - Ziagkos D
AU  - Cheng WC
AU  - Niemeyer-van der Kolk T
AU  - Korsten J
AU  - Gruszka A
AU  - Schmitz-Rohmer D
AU  - Bonnel D
AU  - Legouffe R
AU  - Barré F
AU  - Bekkenk MW
AU  - de Haas ERM
AU  - Quint KD
AU  - Schnidar H
AU  - Rolli M
AU  - Streefkerk HJ
AU  - Burggraaf J
AU  - Vermeer MH
AU  - Rissmann R
PY  - 2023
JO  - Cancers
DO  - 10.3390/cancers15051485
UR  - https://doi.org/10.3390/cancers15051485
ER  -

APA

SS, W., MAA, J., M, R., MJ, V. E., D, Z., WC, C., T, N. D. K., J, K., A, G., D, S., D, B., R, L., F, B., MW, B., ERM, D. H., KD, Q., H, S., M, R., HJ, S., J, B., MH, V., & R, R. (2023). Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510.. Cancers. https://doi.org/10.3390/cancers15051485

Source records

pubmed · retrieved 2026-09-27T14:33:07.865Z